journal article·2020-07

Proteome analysis of secretions from human monocyte-derived macrophages post-exposure to biomaterials and the effect of secretions on cardiac fibroblast fibrotic character

Suja Shrestha, Meghan J. McFadden, Anthony O. Gramolini, J. Paul Santerre

Acta Biomaterialia· Volume 111
Publisher page

Abstract

The use of exogenous biomolecules (BM) for the purpose of repairing and regenerating damaged cardiac tissue can yield serious side effects if used for prolonged periods. As well, such strategies can be cost prohibitive depending on the regiment and period of time applied. Alternatively, autologous monocytes/monocyte-derived macrophages (MDM) can provide a viable path towards generating an endogenous source of stimulatory BM. Biomaterials are often considered as delivery vehicles to generate unique profiles of such BM in tissues or to deliver autologous cells, that can influence the nature of BM produced by the cells. MDM cultured on a degradable polar hydrophobic ionic (D-PHI) polyurethane has previously demonstrated a propensity to increase select anti-inflammatory cytokines, and therefore there is good rationale to further investigate a broader spectrum of the cells' BM in order to provide a more complete proteomic analysis of human MDM secretions induced by D-PHI. Further, it is of interest to assess the potential of such BM to influence cells involved in the reparative state of vital tissues such as those that affect cardiac cell function. Hence, this current study examines the proteomic profile of MDM secretions using mass spectrometry for the first time, along with ELISA, following their culture on D-PHI, and compares them to two important reference materials, poly(lactic-co-glycolic acid) (PLGA) and tissue culture polystyrene (TCPS). Secretions collected from D-PHI cultured MDM led to higher levels of regenerative BM, AGRN, TGFBI and ANXA5, but lower levels of pro-fibrotic BM, MMP7, IL-1β, IL-6 and TNFα, when compared to MDM secretions collected from PLGA and TCPS. In the application to cardiac cell function, the secretion collected from D-PHI cultured MDM led to more human cardiac fibroblast (HCFs) migration. A lower collagen gel contraction induced by MDM secretions collected from D-PHI was supported by gene array analysis for human fibrosis-related genes. The implication of these findings is that more tailored biomaterials such as D-PHI, may lead to a lower pro-inflammatory phenotype of macrophages when used in cardiac tissue constructs, thereby enabling the development of vehicles for the delivery of interventional therapies, or be applied as coatings for sensor implants in cardiac tissue that minimize fibrosis. The general approach of using synthetic biomaterials in order to induce MDM secretions in a manner that will guide favorable regeneration will be critical in making the choice of biomaterials for tissue regeneration work in the future. STATEMENT OF SIGNIFICANCE: Immune modulation strategies currently applied in cardiac tissue repair are mainly based on the delivery of defined exogenous biomolecules. However, the use of such biomolecules may pose wide ranging systemic effects, thereby rendering them clinically less practical. The chemistry of biomaterials (used as a potential targeted delivery modality to circumvent the broad systemic effects of biomolecules) can not only affect acute and chronic toxicity but also alters the timeframe of the wound healing cascade. In this context, monocytes/monocyte-derive macrophages (MDM) can be harnessed as an immune modulating strategy to promote wound healing by an appropriate choice of the biomaterial. However, there are limited reports on the complete proteome analysis of MDM and their reaction of biomaterial related interventions on cardiac tissues and cells. No studies to date have demonstrated the complete proteome of MDM secretions when these cells were cultured on a non-traditional immune modulatory ionomeric polyurethane D-PHI film. This study demonstrated that MDM cultured on D-PHI expressed significantly higher levels of AGRN, TGFBI and ANXA5 but lower levels of MMP7, IL-1β, IL-6 and TNFα when compared to MDM cultured on a well-established degradable biomaterials in the medical field, e.g. PLGA and TCPS, which are often used as the relative standards for cell culture work in the biomaterials field. The implications of these findings have relevance to the repair of cardiac tissues. In another aspect of the work, human cardiac fibroblasts showed significantly lower contractility (low collagen gel contraction and low levels of ACTA2) when cultured in the presence of MDM secretions collected after culturing them on D-PHI compared to PLGA and TCPS. The findings place emphasis on the importance of making the choice of biomaterials for tissue engineering and regenerative medicine applied to their use in cardiac tissue repair.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications · Peptidase Inhibition and Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (74)

Show source-provided references
1. Foreign body reaction to biomaterials10.1016/j.smim.2007.11.004 ↗
2. Exploring the full spectrum of macrophage activation10.1038/nri2448 ↗
3. Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine10.1016/j.biomaterials.2012.02.034 ↗
4. Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials10.1016/j.actbio.2011.11.031 ↗
5. Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial10.1016/S0140-6736(08)60134-8 ↗
6. Ex vivo activated human macrophages improve healing, remodeling, and function of the infarcted heart
7. Antiinflammatory therapy with Canakinumab for atherosclerotic disease10.1056/NEJMoa1707914 ↗
8. IL-4 as a repurposed biological drug for myocardial infarction through augmentation of reparative cardiac macrophages: proof-of-concept data in mice10.1038/s41598-017-07328-z ↗
9. Macrophage colony-stimulating factor treatment after myocardial infarction attenuates left ventricular dysfunction by accelerating infarct repair10.1016/j.jacc.2005.09.037 ↗
10. Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells10.1002/jbm.a.31221 ↗
11. Monocyte/macrophage cytokine activity regulates vascular smooth muscle cell function within a degradable polyurethane scaffold10.1016/j.actbio.2013.12.022 ↗
12. Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets10.1074/mcp.M600465-MCP200 ↗
13. Quantitative proteomics analyses of activation states of human THP-1 macrophages10.1016/j.jprot.2015.07.013 ↗
14. Quantitative proteomics of extracellular vesicles released from human monocyte-derived macrophages upon β-glucan stimulation10.1021/pr4012552 ↗
15. A combination of proteomics, principal component analysis and transcriptomics is a powerful tool for the identification of biomarkers for macrophage maturation in the U937 cell line10.1002/pmic.200300669 ↗
16. How Biomaterials Can Influence Various Cell Types in the Repair and Regeneration of the Heart after Myocardial Infarction10.3389/fbioe.2016.00062 ↗
17. Functional characterization of human coronary artery smooth muscle cells under cyclic mechanical strain in a degradable polyurethane scaffold10.1016/j.biomaterials.2011.03.034 ↗
18. Use of monocyte/endothelial cell co-cultures (in vitro) and a subcutaneous implant mouse model (in vivo) to evaluate a degradable polar hydrophobic ionic polyurethane10.1002/jcb.23307 ↗
19. Differences in protein binding and cytokine release from monocytes on commercially sourced tissue culture polystyrene10.1016/j.actbio.2011.09.015 ↗
20. Protein binding mediation of biomaterial-dependent monocyte activation on a degradable polar hydrophobic ionic polyurethane10.1016/j.biomaterials.2012.08.014 ↗
21. Structural and functional characterisation of cardiac fibroblasts10.1016/j.cardiores.2004.08.020 ↗
22. The effect of degradable polymer surfaces on co-cultures of monocytes and smooth muscle cells10.1016/j.biomaterials.2011.01.069 ↗
23. Effect of polyurethane chemistry and protein coating on monocyte differentiation towards a wound healing phenotype macrophage10.1016/j.biomaterials.2009.07.010 ↗
24. Limited Endothelial Plasticity of Mesenchymal Stem Cells Revealed by Quantitative Phenotypic Comparisons to Representative Endothelial Cell Controls10.1002/sctm.18-0127 ↗
25. Andromeda: a peptide search engine integrated into the MaxQuant environment10.1021/pr101065j ↗
26. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ10.1074/mcp.M113.031591 ↗
27. Pathway enrichment analysis and visualization of omics data using g:profiler, GSEA, Cytoscape and EnrichmentMap10.1038/s41596-018-0103-9 ↗
28. Pathway analysis of dilated cardiomyopathy using global proteomic profiling and enrichment maps10.1002/pmic.200900412 ↗
29. g:profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)10.1093/nar/gkz369 ↗
30. Effects of interleukin-18 on cardiac fibroblast function and gene expression10.1016/j.cyto.2010.10.002 ↗
31. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro10.1073/pnas.76.3.1274 ↗
32. Studies on the mechanism of hydrated collagen gel reorganization by human skin fibroblasts10.1242/jcs.79.1.67 ↗
33. Contraction of hydrated collagen gels by fibroblasts: evidence for two mechanisms by which collagen fibrils are stabilized10.1016/S0174-173X(87)80050-X ↗
34. Human cardiac fibroblast extracellular matrix remodeling: dual effects of tissue inhibitor of metalloproteinase-210.1016/j.carpath.2014.06.003 ↗
35. The extracellular matrix protein agrin promotes heart regeneration in mice10.1038/nature22978 ↗
36. Macrophages produce TGF-beta-induced (beta-ig-h3) following ingestion of apoptotic cells and regulate MMP14 levels and collagen turnover in fibroblasts10.4049/jimmunol.180.7.5036 ↗
37. The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in duchenne muscular dystrophy cardiomyopathy10.1016/j.cardfail.2019.02.006 ↗
38. Recombinant human annexin a5 can repair the disrupted Cardiomyocyte Adherens junctions in Endotoxemia10.1097/SHK.0000000000000370 ↗
39. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation10.1161/CIRCRESAHA.109.209189 ↗
40. Tumor necrosis factor-alpha at acute myocardial infarction in rats and effects on cardiac fibroblasts10.1006/jmcc.1999.1007 ↗
41. Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones10.1016/j.cardiores.2007.06.003 ↗
42. Myofibroblasts in the infarct area: concepts and challenges10.1017/S143192761101227X ↗
43. Bone marrow-derived CXCR4+ cells mobilized by macrophage colony-stimulating factor participate in the reduction of infarct area and improvement of cardiac remodeling after myocardial infarction in mice10.2353/ajpath.2007.061276 ↗
44. Myofibroblasts and inflammatory cells as players of cardiac fibrosis10.1007/s12272-016-0809-6 ↗
45. Hypoxia-Induced Changes in the Fibroblast Secretome, Exosome, and Whole-Cell Proteome Using Cultured, Cardiac-Derived Cells Isolated from Neonatal Mice10.1021/acs.jproteome.7b00144 ↗
46. Combined effects of interleukin-1α and transforming growth factor-β1 on modulation of human cardiac fibroblast function10.1016/j.matbio.2013.03.008 ↗
47. Protein and surface effects on monocyte and macrophage adhesion, maturation, and survival10.1002/jbm.10043 ↗
48. A critical role for the membrane-type 1 matrix metalloproteinase in collagen phagocytosis10.1091/mbc.e06-06-0486 ↗
49. Fibroblasts in myocardial infarction: a role in inflammation and repair10.1016/j.yjmcc.2013.11.015 ↗
50. The big five in fibrosis: macrophages, myofibroblasts, matrix, mechanics, and miscommunication10.1016/j.matbio.2018.01.019 ↗
51. The myofibroblast in wound healing and fibrosis: answered and unanswered questions10.12688/f1000research.8190.1 ↗
52. The functional behavior of a macrophage/fibroblast co-culture model derived from normal and diabetic mice with a marine gelatin-oxidized alginate hydrogel10.1016/j.biomaterials.2010.04.022 ↗
53. Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease10.1186/1755-1536-5-15 ↗
54. Collagen chain mRNAs in isolated heart cells from young and adult rats10.1016/S0022-2828(88)80059-2 ↗
55. Regulation of collagen degradation in the rat myocardium after infarction10.1016/S0022-2828(05)82390-9 ↗
56. Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro10.1161/01.RES.86.12.1259 ↗
57. Matrix metalloproteinase inhibitors reduce collagen gel contraction and alpha-smooth muscle actin expression by periodontal ligament cells10.1111/j.1600-0765.2008.01127.x ↗
58. Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts10.1152/ajpheart.00402.2004 ↗
59. Mechanical control of cardiac myofibroblasts10.1016/j.yjmcc.2015.11.025 ↗
60. Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts10.1161/01.cir.0000032893.55215.fc ↗
61. Engineered heart tissue for regeneration of diseased hearts10.1016/S0142-9612(03)00521-0 ↗
62. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat10.1161/CIRCULATIONAHA.107.727420 ↗
63. Alginate biomaterial for the treatment of myocardial infarction: progress, translational strategies, and clinical outlook: from ocean algae to patient bedside10.1016/j.addr.2015.04.021 ↗
64. The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment10.1016/j.biomaterials.2011.12.044 ↗
65. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction10.1089/107632704323061762 ↗
66. Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction10.1016/j.jconrel.2013.04.022 ↗
67. Novel injectable biomimetic hydrogels with carbon nanofibers and self assembled rosette nanotubes for myocardial applications10.1002/jbm.a.34400 ↗
68. Polymeric scaffold aided stem cell therapeutics for cardiac muscle repair and regeneration10.1002/mabi.201300223 ↗
69. Decellularized matrices for tissue engineering10.1517/14712598.2010.534079 ↗
70. Allograft Heart Valves: current Aspects and Future Applications10.1089/bio.2016.0070 ↗
71. Cardiac tissue engineering: regeneration of the wounded heart10.1016/j.copbio.2004.08.007 ↗
72. Heart regeneration after myocardial infarction using synthetic biomaterials10.1016/j.jconrel.2015.02.009 ↗
73. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients10.1161/01.CIR.0000017264.66561.3D ↗
74. Late durability of decellularized allografts for aortic valve replacement: a word of caution10.1016/j.jtcvs.2016.03.050 ↗